Danaher (DHR) Stock
NASDAQ · DHR
215.84
Fundamentals
Market cap
$148.90B
Price / Earnings ratio
37.2x
Price / Sales ratio
5.9x
Price / Book ratio
2.8x
Return on assets
0.1%
Ex-Dividend date
26 Jun 2026
Last payment date
N/A
Dividend amount
$0.40
Dividend yield
0.7%
Debt / Equity ratio
N/A
Latest news
About Danaher
Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets.
SectorHealthcare
IndustryDiagnostics & Research
Employees58,000
CEOMr. Rainer M. Blair
IPO DateJan 5, 1979
HeadquartersWashington, DC
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Steven M. Rales | Co-Founder & Chairman | 1951 |
| Mr. Rainer M. Blair | President, CEO & Director | 1964 |
| Mr. Mitchell P. Rales | Co-Founder & Director | 1957 |
| Dr. Jose-Carlos Gutierrez-Ramos Ph.D. | Senior VP & Chief Science Officer | 1962 |
| Mr. Matthew R. McGrew | Executive Vice President | 1972 |
| Mr. Christopher Paul Riley | Executive VP of Biotechnology Group & CEO of Cytiva | 1974 |
| Ms. Julie Sawyer Montgomery | Executive Vice President of Diagnostics Platform | 1972 |
| Mr. Matthew E. Gugino C.F.A., CPA | Executive VP & CFO | 1983 |
| Mr. Christopher M. Bouda | VP & Chief Accounting Officer | — |
| Ms. Rachel Marie Vatnsdal Olson | Vice President of Investor Relations | — |
Fundamentals
Valuation
Market cap$148.90B
Price-to-sales ratio5.93
Price-to-book value2.83
Price-earnings ratio37.20
Return on Equity7.00%
Return on Sales0.19%
Return on Assets0.05%
PEG ratio1.25
Earnings Per Share
Earnings Per Share$5.65
Income Statement
Average volume3,555,862
EBITDA$7.09B
1 year high (52w)$242.80
1 year low (52w)$160.93
Dividend
Ex dividend date26 Jun 2026
Dividend amount$0.40
Dividend yield0.67%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



